PRKAA1 and neoplasm: In agreement with these findings, increased AMPK/pAMPK expression is indicative of favorable survival in patients with carcinomas of the uterine cervix [10], ovary [11], and liver [12] whose tumor cells display cytoplasmic AMPK/pAMPK immunohistochemical (IHC) staining.